# BriaCell Therapeutics Corp.: Form 8-K, filed Jul 18, 2024

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 8-K
- Filed: 2024-07-18
- Accepted by EDGAR: Jul 18, 2024, 16:30 ET
- Period: 2024-07-18
- Accession: 0001493152-24-028343
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224028343/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315224028343/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315224028343/form8-k.htm

Filed Jul 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-028343. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.